HCA Healthcare (HCA) board of directors has authorized an additional share repurchase program for up to $10B of the company’s outstanding common stock. Repurchases will be made in accordance with applicable securities laws and may be made at management’s discretion from time to time in the open market, through privately negotiated transactions, or otherwise. The repurchase program has no time limit and may be suspended for periods or discontinued at any time.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- Options Volatility and Implied Earnings Moves Today, January 24, 2025
- Notable companies reporting before tomorrow’s open
- HCA Earnings this Week: How Will it Perform?
- Trump Trade: EV ‘battery belt’ towns betting Trump won’t remove subsidies
- HCA Healthcare price target lowered to $370 from $420 at KeyBanc